Harmful delayed effects of exogenous isolation enzymes on isolated human islets: relevance to clinical transplantation.
The isolation process exposes human pancreatic islets to exogenous isolation enzymes. Exposure to these enzymes, as a result of intraductal injection in the pancreas or simple contact of islets with enzyme components, causes internalization into the islet cells of enzymes and their by-products. Human islets exposed to Liberase-HI exhibit a decreased insulin secretory ability that correlates with the time of exposure. This phenomenon is paralleled by increased expression of adhesion molecules (CD106 and CD62p) and activation of apoptotic pathways (Bax and Bcl-2) in islet cells. Increased functional impairment is also observed after islet transplantation in diabetic immunodeficient mice. Experimental exposure of islet grafts to exogenous isolation enzymes causes intense inflammation (CD11b positive cells) at the transplant site and it was associated with sickness behavior and eventually death of mouse recipients. The extent of these adverse effects likely deceives the standard qualitative protocols currently in use to assess islet quality in vitro. Reducing the secondary effects of exogenous isolation enzymes on isolated human islets may be crucial to enhance the quality of islets as tissue grafts.
Balamurugan
A N
AN
Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
He
Jing
J
Guo
Fengli
F
Stolz
Donna B
DB
Bertera
Suzanne
S
Geng
Xuehui
X
Ge
Xinhui
X
Trucco
Massimo
M
Bottino
Rita
R
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D017364:Collagenases / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D016381:Islets of Langerhans Transplantation / Q000473:pathology / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D018613:Microscopy, Confocal; D016253:Microscopy, Immunoelectron; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D013820:Thermolysin / Q000493:pharmacokinetics / Q000494:pharmacology*; D051028:bcl-2-Associated X Protein / Q000378:metabolism
D007328:Insulin; D019253:Proto-Oncogene Proteins c-bcl-2; D051028:bcl-2-Associated X Protein; D017364:Collagenases; C106635:Liberase; D013820:Thermolysin